FluoGuide A/S is Awarded Best IPO in 2019 by the Independent IPO Guide
FluoGuide is awarded Best IPO in 2019 by the independent IPO Guide, the Companyโs first product, FG001, is designed to improve surgical precisioโฆ
b3cnewswire.com
FluoGuide is awarded Best IPO in 2019 by the independent IPO Guide, the Companyโs first product, FG001, is designed to improve surgical precisioโฆ
WISE, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing,โฆ
BC Platforms has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA. The round was led by IQVIA. As paโฆ
Confo Therapeutics and DyNAbind announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR). The collaboration wโฆ